ImmuniMed Investment Opportunity

2 months ago
41

mmuniMed Inc., is a clinical-stage Canadian Biopharmaceutical Company focused on developing novel Oral Dose Therapeutic Antibodies for unmet medical needs.

Our innovative technology produces antibodies targeting specific pathogens like Clostridioides Difficile bacteria.

website: www.immunimed.com

#cdifficile #cdiff

Loading 1 comment...